VITAL FLU VACCINE STOCK ORDERING & SUPPLY INFORMATION for 2018/19: Supply of adjuvanted trivalent influenza vaccine to be phased and deadline to order extended UNTIL Thursday 12th April 2018.

VITAL FLU VACCINE STOCK ORDERING & SUPPLY INFORMATION for 2018/19: Supply of adjuvanted trivalent influenza vaccine to be phased and deadline to order extended UNTIL Thursday 12th April 2018.

April 5, 2018

Earlier this year, NHS England wrote to community pharmacy contractors and general practices to advise them that for the 2018/19 flu vaccination campaign, adjuvanted trivalent influenza vaccine (aTIV) (Fluad, Seqirus) should be offered to all those aged 65 and over, whilst adults aged under 65 in clinical at-risk groups should be offered a quadrivalent influenza vaccine (QIV).

Key points are:

  • Extended window for ordering aTIV to UNTILThursday 12th April 2018. Seqirus, the manufacturer of aTIV has confirmed to the Department of Health and Social Care (DHSC), Public Health England (PHE) and NHS England that they can supply enough vaccine for the population aged 65 years and over in the UK. The manufacturer has increased planned production and, following a request made by PSNC.
  • Deliveries of aTIV to pharmacies and general practices across the UK will be phased. Please read the PSNC briefing above for timelines as you may wish to review your existing order by Thursday 12th April 2018.
  • The phased deliveries mean that a prioritisation approach will probably need to be adopted for the 65 years and over cohort. More information in the briefing.

 

Further information can be found in this PSNC Briefing provides an important update for contractors.  This is an ESSENTIAL READ:

PSNC Briefing 018/18: Flu Vaccination Service 2018/19 – important update for contractors (March 2018)

Some pharmacies/multiples will arrange for this to be handled centrally, please check with your company managers/head office to find out the company procedure for your pharmacy.

If you have any queries on this PSNC Briefing or you require more information, please contact Zainab Al-Kharsan, PSNC Service Development Pharmacist.

 

 

Fortunately, the SE local office had already made local funds available for aTIV and QIV vaccines for 2018/19. Here is the NHS England South (South East) position statement

If you have any queries, about this letter or advice, please contact:

Dawn Hollis

Public Health Commissioning Manager

NHS England South (South East)

Email: dawn.hollis@nhs.net

Mobile: 07896 504117




More Latest News >